ROTH logo

PharmaRoth Labs OTCPK:ROTH Stock Report

Last Price

US$0.000001

Market Cap

US$390.0

7D

0%

1Y

n/a

Updated

27 Mar, 2024

Data

Company Financials

ROTH Stock Overview

PharmaRoth Labs, Inc. operates as a nutraceutical company worldwide.

ROTH fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

PharmaRoth Labs, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for PharmaRoth Labs
Historical stock prices
Current Share PriceUS$0.000001
52 Week HighUS$0.0001
52 Week LowUS$0.000001
Beta0
1 Month Change0%
3 Month Changen/a
1 Year Changen/a
3 Year Change-99.94%
5 Year Change-99.94%
Change since IPO-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

ROTHUS Personal ProductsUS Market
7D0%-1.8%1.3%
1Yn/a-27.1%29.8%

Return vs Industry: Insufficient data to determine how ROTH performed against the US Personal Products industry.

Return vs Market: Insufficient data to determine how ROTH performed against the US Market.

Price Volatility

Is ROTH's price volatile compared to industry and market?
ROTH volatility
ROTH Average Weekly Movementn/a
Personal Products Industry Average Movement9.8%
Market Average Movement6.0%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.0%

Stable Share Price: ROTH's share price has been volatile over the past 3 months.

Volatility Over Time: Insufficient data to determine ROTH's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2000n/aLuis Manuel Lopezhttps://www.feroindustries.com

PharmaRoth Labs, Inc. operates as a nutraceutical company worldwide. It focuses on producing, marketing, and distributing Sucanon, an herbal-based nutraceutical treatment for type-2 diabetes. The company was formerly known as Fero Industries Inc. and changed its name to PharmaRoth Labs, Inc. in March 2013.

PharmaRoth Labs, Inc. Fundamentals Summary

How do PharmaRoth Labs's earnings and revenue compare to its market cap?
ROTH fundamental statistics
Market capUS$390.00
Earnings (TTM)-US$557.63k
Revenue (TTM)US$200.15k

0.0x

P/S Ratio

0.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ROTH income statement (TTM)
RevenueUS$200.15k
Cost of RevenueUS$119.67k
Gross ProfitUS$80.48k
Other ExpensesUS$638.10k
Earnings-US$557.63k

Last Reported Earnings

Mar 31, 2011

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did ROTH perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.